机译:减少循环中性粒细胞的发生并伴有1型糖尿病
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy,Vita-Salute San Raffaele University, Milan, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy,Tor-Vergata University, Rome, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy,Department of Internal Medicine, San Raffaele Hospital, Milan, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy;
Department of Internal Medicine, San Raffaele Hospital, Milan, Italy,TrialNet Clinical Center, San Raffaele Hospital, Milan, Italy;
Department of Internal Medicine, San Raffaele Hospital, Milan, Italy,TrialNet Clinical Center, San Raffaele Hospital, Milan, Italy;
Diabetes Unit, Department of Internal Medicine, Endocrine and Metabolic Sciences, and Biochemistry, University of Siena Fondazione Umberto Di Mario ONLUS c/o Toscana Life Science, Siena, Italy;
Department of Experimental Pathology, University of Pisa, Pisa, Italy;
San Raffaele Scientific Institute, Division of Regenerative Medicine, Stem Cells and Gene Therapy, Milan, Italy;
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Interdepartmental Center of Cytometry, Milan, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy,Department of Paediatrics and Neonatology, San Raffaele Hospital, Milan, Italy;
Department of Paediatrics and Neonatology, San Raffaele Hospital, Milan, Italy;
Department of Paediatric Orthopaedics, San Raffaele Hospital, Milan, Italy;
Department of Urology, San Raffaele Hospital, Milan, Italy;
Department of Immunohematology and Transfusion Medicine, San Raffaele Hospital, Milan, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy;
Department of Endocrinology and Metabolism, University of Pisa, and Unit of Endocrinology and Metabolism of Transplantation, Azienda Ospedaliera Univeristaria Pisana, Pisa, Italy;
Diabetes Unit, Department of Internal Medicine, Endocrine and Metabolic Sciences, and Biochemistry, University of Siena Fondazione Umberto Di Mario ONLUS c/o Toscana Life Science, Siena, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy,Vita-Salute San Raffaele University, Milan, Italy,TrialNet Clinical Center, San Raffaele Hospital, Milan, Italy;
San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy,TrialNet Clinical Center, San Raffaele Hospital, Milan, Italy;
机译:高剂量葡萄糖诱导良好控制的2型糖尿病的循环中性粒细胞胞外陷阱水平及其形成途径
机译:I型糖尿病肾病合并糖尿病的患者肾小球滤过率略有降低,并伴有胰岛素抵抗。
机译:在日本儿童中,停止接种BCG疫苗比2型糖尿病患者明显减少。炎症和皮质醇活性作为2型糖尿病病因的作用
机译:在秘鲁使用远程保健解决方案减少2型糖尿病引起的并发症
机译:糖尿病自我管理教育在2型糖尿病中患有2型糖尿病患者中HBA1C的有效性
机译:减少循环中性粒细胞的发生并伴有1型糖尿病
机译:循环中性粒细胞减少先于并伴有1型糖尿病。